Effect of Prebiotics on Hyperuricemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Hyperuricemia is a major risk factor for many chronic diseases. Recently, dysbiosis of gut microbiota has been reported to play an important role in the pathogenesis of Hyperuricemia. Animal studies have demonstrated that administration of prebiotics help delay the progression of Hyperuricemia through several mechanisms. This trial aims to examine its protective effect in humans.
Epistemonikos ID: a20f697930e550f025c73ce9d73ebaaaeb1b4021
First added on: May 13, 2024